PortalPublikationenAnalysis of minimal residual disease by Ig/TCR gene rearrang...

Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data.

Standard

Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data. / van der Velden, V H J; Cazzaniga, G; Schrauder, A; Hancock, J; Bader, P; Panzer-Grumayer, E R; Flohr, T; Sutton, R; Cave, H; Madsen, H O; Cayuela, J M; Trka, J; Eckert, C; Foroni, L; Zur Stadt, Udo; Beldjord, K; Raff, T; van der Schoot, C E; van Dongen, J J M.

in: LEUKEMIA, Jahrgang 21, Nr. 4, 4, 2007, S. 604-611.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

van der Velden, VHJ, Cazzaniga, G, Schrauder, A, Hancock, J, Bader, P, Panzer-Grumayer, ER, Flohr, T, Sutton, R, Cave, H, Madsen, HO, Cayuela, JM, Trka, J, Eckert, C, Foroni, L, Zur Stadt, U, Beldjord, K, Raff, T, van der Schoot, CE & van Dongen, JJM 2007, 'Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data.', LEUKEMIA, Jg. 21, Nr. 4, 4, S. 604-611. <http://www.ncbi.nlm.nih.gov/pubmed/17287850?dopt=Citation>

APA

van der Velden, V. H. J., Cazzaniga, G., Schrauder, A., Hancock, J., Bader, P., Panzer-Grumayer, E. R., Flohr, T., Sutton, R., Cave, H., Madsen, H. O., Cayuela, J. M., Trka, J., Eckert, C., Foroni, L., Zur Stadt, U., Beldjord, K., Raff, T., van der Schoot, C. E., & van Dongen, J. J. M. (2007). Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data. LEUKEMIA, 21(4), 604-611. [4]. http://www.ncbi.nlm.nih.gov/pubmed/17287850?dopt=Citation

Vancouver

van der Velden VHJ, Cazzaniga G, Schrauder A, Hancock J, Bader P, Panzer-Grumayer ER et al. Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data. LEUKEMIA. 2007;21(4):604-611. 4.

Bibtex

@article{def21bf105d44994b4a7dc41450e97de,
title = "Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data.",
abstract = "Most modern treatment protocols for acute lymphoblastic leukaemia (ALL) include the analysis of minimal residual disease (MRD). To ensure comparable MRD results between different MRD-polymerase chain reaction (PCR) laboratories, standardization and quality control are essential. The European Study Group on MRD detection in ALL (ESG-MRD-ALL), consisting of 30 MRD-PCR laboratories worldwide, has developed guidelines for the interpretation of real-time quantitative PCR-based MRD data. The application of these guidelines ensures identical interpretation of MRD data between different laboratories of the same MRD-based clinical protocol. Furthermore, the ESG-MRD-ALL guidelines will facilitate the comparison of MRD data obtained in different treatment protocols, including those with new drugs.",
author = "{van der Velden}, {V H J} and G Cazzaniga and A Schrauder and J Hancock and P Bader and Panzer-Grumayer, {E R} and T Flohr and R Sutton and H Cave and Madsen, {H O} and Cayuela, {J M} and J Trka and C Eckert and L Foroni and {Zur Stadt}, Udo and K Beldjord and T Raff and {van der Schoot}, {C E} and {van Dongen}, {J J M}",
year = "2007",
language = "Deutsch",
volume = "21",
pages = "604--611",
journal = "LEUKEMIA",
issn = "0887-6924",
publisher = "NATURE PUBLISHING GROUP",
number = "4",

}

RIS

TY - JOUR

T1 - Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data.

AU - van der Velden, V H J

AU - Cazzaniga, G

AU - Schrauder, A

AU - Hancock, J

AU - Bader, P

AU - Panzer-Grumayer, E R

AU - Flohr, T

AU - Sutton, R

AU - Cave, H

AU - Madsen, H O

AU - Cayuela, J M

AU - Trka, J

AU - Eckert, C

AU - Foroni, L

AU - Zur Stadt, Udo

AU - Beldjord, K

AU - Raff, T

AU - van der Schoot, C E

AU - van Dongen, J J M

PY - 2007

Y1 - 2007

N2 - Most modern treatment protocols for acute lymphoblastic leukaemia (ALL) include the analysis of minimal residual disease (MRD). To ensure comparable MRD results between different MRD-polymerase chain reaction (PCR) laboratories, standardization and quality control are essential. The European Study Group on MRD detection in ALL (ESG-MRD-ALL), consisting of 30 MRD-PCR laboratories worldwide, has developed guidelines for the interpretation of real-time quantitative PCR-based MRD data. The application of these guidelines ensures identical interpretation of MRD data between different laboratories of the same MRD-based clinical protocol. Furthermore, the ESG-MRD-ALL guidelines will facilitate the comparison of MRD data obtained in different treatment protocols, including those with new drugs.

AB - Most modern treatment protocols for acute lymphoblastic leukaemia (ALL) include the analysis of minimal residual disease (MRD). To ensure comparable MRD results between different MRD-polymerase chain reaction (PCR) laboratories, standardization and quality control are essential. The European Study Group on MRD detection in ALL (ESG-MRD-ALL), consisting of 30 MRD-PCR laboratories worldwide, has developed guidelines for the interpretation of real-time quantitative PCR-based MRD data. The application of these guidelines ensures identical interpretation of MRD data between different laboratories of the same MRD-based clinical protocol. Furthermore, the ESG-MRD-ALL guidelines will facilitate the comparison of MRD data obtained in different treatment protocols, including those with new drugs.

M3 - SCORING: Zeitschriftenaufsatz

VL - 21

SP - 604

EP - 611

JO - LEUKEMIA

JF - LEUKEMIA

SN - 0887-6924

IS - 4

M1 - 4

ER -